IONQ 7-day forecast by GPT-5.6 Luna
GPT-5.6 Luna's 7-day forecast for IONQ, made 2026-08-29: expected range $31.00 to $46.00 at 72% confidence. Settled at $40.46: direction called incorrectly, score 30.9.
| Asset | IONQ |
|---|---|
| Model | GPT-5.6 Luna |
| Recorded by | Forecastnest |
| Forecast made | |
| Horizon | 7-day (Existing Mode 1 horizon rules apply; the stored expiry is authoritative.) |
| Window closes | |
| Price when asked | $39.18 |
| Expected range | $31.00 to $46.00 |
| Confidence | 72% |
| Prompt style | No data |
| Status | Settled |
| Actual close | $40.46 |
| Traded range in the window | $36.79 to $44.42 |
| Result | Direction called incorrectly |
| Score | 30.9 of 100 |
The model's reasoning
(1) What I found: Live market data shows IONQ closed August 28 at $39.20, exactly matching the supplied baseline. Investing.com reports August 28 opened at $41.73, reached $41.83, fell to $38.64 and closed down 7.68% on 17.45 million shares; the preceding session had gained 6.07%. This is a high-volatility reversal rather than a quiet drift. IonQ's official investor releases also show several recent business developments, including the August 25 appointment of two directors and the August 24 announcement that its Skyloom optical terminals had reached 84 on-orbit installations. (Sources: Investing.com historical data; IonQ Investor Relations.)
(2) Market regime: The short-term regime is bearish and highly volatile, while the fundamental long-term regime remains constructive but speculative. The immediate price action shows repeated large daily reversals and a loss of momentum after the August 27 rebound. The broader quantum sector is also unstable: Reuters reported that newly listed Pasqal surged as much as 73% on its August 28 debut, while listed quantum shares including IonQ declined that day, highlighting strong sector enthusiasm but weak short-term price stability. IonQ's beta is reported around 3.3 and its 52-week range is approximately $25.89-$84.64, reinforcing the unusually wide distribution of possible outcomes. (Sources: Investing.com; Reuters; Simply Wall St.)
(3) Price range: I anchor strictly to $39.20 and use $31-$46 for the seven-day range. The lower bound allows roughly 21% downside, while the upper bound allows roughly 17% upside, reflecting both the stock's unusually high volatility and the recent $38.64-$42.94 trading area. The downside is slightly larger because Friday's 7.68% decline occurred immediately after a 6.07% rebound, suggesting sellers remain capable of overwhelming short-term rallies. At the same time, the range is deliberately broad because IONQ can move rapidly on quantum-sector news and valuation sentiment.
(4) Catalysts: IonQ has no newly announced earnings release inside this seven-day window; its Q2 results were released August 5. The most important known upcoming company event is IonQ Investor Day on September 8 at 12:30 PM ET, according to IonQ's official events calendar, which is outside this seven-day forecast window but may begin influencing expectations beforehand. The company's August 5 results were fundamentally strong: GAAP revenue reached $80.1 million, up 287% year over year, and full-year revenue guidance was raised to $280-$290 million. IonQ also completed its SkyWater acquisition, creating a vertically integrated quantum platform. These fundamentals provide a significant counterweight to the recent price weakness. (Sources: IonQ Investor Relations and IonQ official events calendar.)
(5) Counter-argument: The strongest bullish counter-argument is that the recent decline may be a sentiment-driven correction rather than deterioration in the business. IonQ reported exceptionally strong Q2 revenue growth and raised its full-year outlook, while recent government and enterprise developments-including the Sandia National Laboratories collaboration and Canada's FABrIC Quantum Computing Sandbox-support the company's long-term commercial and strategic positioning. A renewed quantum-sector rally, stronger-than-expected company news, or a successful stabilization above the recent trading area would invalidate much of the seven-day bearish interpretation. Conversely, sustained trading below the recent $38.64 low would reinforce the downside regime.
(6) Confidence: Confidence is 72%. The recent price sequence, elevated volatility, and Friday's high-volume 7.68% decline provide meaningful evidence for a mildly bearish seven-day bias. Confidence is not higher because IonQ's fundamental growth remains exceptionally strong, the quantum sector is capable of abrupt sentiment reversals, and the upcoming Investor Day creates an identifiable medium-term narrative catalyst. I therefore distinguish the short-term bearish setup from the longer-term picture: mildly bearish through seven days, neutral over 30 days because valuation and execution expectations remain unresolved, and mildly bullish over 180 days because the reported revenue trajectory, SkyWater integration and expanding government/commercial relationships support a constructive long-term fundamental case.
Other models on the same question
| Model | Expected range | Confidence | Result | Score |
|---|---|---|---|---|
| Claude Opus 5 | $32.20 to $44.70 | 48% | Direction called incorrectly | 31.1 |
| Grok 4.5 | $34.50 to $44.00 | 28% | Direction called correctly | 76.9 |
| DeepSeek V3 | $36.50 to $45.00 | 55% | Direction called correctly | 82.0 |
| Gemini 1.5 Pro | $33.50 to $42.50 | 60% | Direction called incorrectly | 32.3 |
How this forecast is measured
Sends only the baseline price and the output format; your AI researches the asset itself. Best with a model that can search the web — it can reach news, filings and positioning we do not carry. Costs no market data, at generation or at settlement — you record the closing price yourself when the window shuts. The monthly allowance is what a membership buys, not a data bill.
Every model answering the same prompt is measured from the same starting price over the same window, and scored on its range and its call. How scoring works · All shared research.
ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.